PEG minocycline-liposomes ameliorate CNS autoimmune disease.
about
IL-1β is overexpressed and aberrantly regulated in corticosteroid nonresponders with autoimmune inner ear disease.PET and MR imaging of neuroinflammation in hepatic encephalopathy.A novel target of action of minocycline in NGF-induced neurite outgrowth in PC12 cells: translation initiation [corrected] factor eIF4AI.Improving outcomes of neuroprotection by minocycline: guides from cell culture and intracerebral hemorrhage in miceMinocycline attenuates microglia activation and blocks the long-term epileptogenic effects of early-life seizures.Nanoliposomal minocycline for ocular drug deliveryTargeted drug-delivery approaches by nanoparticulate carriers in the therapy of inflammatory diseases.Drug delivery technologies for autoimmune disease.Serum levels of matrix metalloproteinases: implications in clinical neurology.Lymph node-derived donor encephalitogenic CD4+ T cells in C57BL/6 mice adoptive transfer experimental autoimmune encephalomyelitis highly express GM-CSF and T-bet.Application of nanomedicine for crossing the blood-brain barrier: Theranostic opportunities in multiple sclerosis.Delivering minocycline into brain endothelial cells with liposome-based technology.Minocycline suppresses experimental autoimmune encephalomyelitis by increasing tissue inhibitors of metalloproteinases.Control of autoimmune inflammation using liposomes to deliver positive allosteric modulators of metabotropic glutamate receptors.Regenerative Strategies for the Central Nervous System
P2860
Q30471015-50FEEC4F-9F95-4031-AB13-A830AEE48134Q30878855-22E2FA9E-10A9-4433-A592-31F67B508D5FQ33769000-2E611A13-11E8-41CC-A5EA-BF4E1FA4011CQ34659673-6EEB04F6-A266-4C17-8B24-D7BF7B68E8C3Q35881742-26D89633-6580-43C0-9D29-C3B80941F30CQ37145338-E94A510F-3B7E-4EEF-AB6E-C6842429DC2BQ37638947-3BAAE11D-7F28-422D-98A3-B51AF055FCC1Q37801381-B8428E6E-6143-424E-AFC8-380C8E0AF581Q37977361-A1CE420F-1D43-4925-B112-010EF834DC89Q38261618-DDB8722A-040C-4FB5-B8CE-40CAAE56DFB9Q38896543-A7EE381D-7D9A-4B86-A390-94AF930B07FAQ39366697-FB607AB9-8CA4-451C-9000-8077A2A49163Q44327938-6D9E4E54-A738-4E92-9CBC-A1A03ECCD354Q47846395-C95ADA09-54D4-4991-ABA4-019CA8C9933EQ57460363-AEAE7156-19CE-44B6-A0B8-B641E75F9CD3
P2860
PEG minocycline-liposomes ameliorate CNS autoimmune disease.
description
2009 nî lūn-bûn
@nan
2009 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
PEG minocycline-liposomes ameliorate CNS autoimmune disease.
@ast
PEG minocycline-liposomes ameliorate CNS autoimmune disease.
@en
type
label
PEG minocycline-liposomes ameliorate CNS autoimmune disease.
@ast
PEG minocycline-liposomes ameliorate CNS autoimmune disease.
@en
prefLabel
PEG minocycline-liposomes ameliorate CNS autoimmune disease.
@ast
PEG minocycline-liposomes ameliorate CNS autoimmune disease.
@en
P2093
P2860
P1433
P1476
PEG minocycline-liposomes ameliorate CNS autoimmune disease.
@en
P2093
Elliot M Frohman
Josbert Metselaar
Li-Hong Ben
Mahendra P Singh
Michael K Racke
Petra D Cravens
Todd N Eagar
P2860
P356
10.1371/JOURNAL.PONE.0004151
P407
P577
2009-01-07T00:00:00Z